Targeting AGEs Signaling Ameliorates Central Nervous System Diabetic Complications in Rats

Overview

Journal Adv Pharmacol Sci

Date 2015 Oct 23

PMID 26491434

Citations 5

Authors

Mohamed Naguib Zakaria

Hany M El-Bassossy

Waleed Barakat

Affiliations

Soon will be listed here.

Abstract

Diabetes is a chronic endocrine disorder associated with several complications as hypertension, advanced brain aging, and cognitive decline. Accumulation of advanced glycation end products (AGEs) is an important mechanism that mediates diabetic complications. Upon binding to their receptor (RAGE), AGEs mediate oxidative stress and/or cause cross-linking with proteins in blood vessels and brain tissues. The current investigation was designed to investigate the effect of agents that decrease AGEs signaling, perindopril which increases soluble RAGE (sRAGE) and alagebrium which cleaves AGEs cross-links, compared to the standard antidiabetic drug, gliclazide, on the vascular and central nervous system (CNS) complications in STZ-induced (50 mg/kg, IP) diabetes in rats. Perindopril ameliorated the elevation in blood pressure seen in diabetic animals. In addition, both perindopril and alagebrium significantly inhibited memory decline (performance in the Y-maze), neuronal degeneration (Fluoro-Jade staining), AGEs accumulation in serum and brain, and brain oxidative stress (level of reduced glutathione and activities of catalase and malondialdehyde). These results suggest that blockade of AGEs signaling after diabetes induction in rats is effective in reducing diabetic CNS complications.

Citing Articles

Exploring the Biological Effects of Anti-Diabetic Vanadium Compounds in the Liver, Heart and Brain.

Dayanand Y, Pather R, Xulu N, Booysen I, Sibiya N, Khathi A Diabetes Metab Syndr Obes. 2024; 17:3267-3278.

PMID: 39247428 PMC: 11380877. DOI: 10.2147/DMSO.S417700.

Maternal n-7 Unsaturated Fatty Acids Protect the Fetal Brain from Neuronal Degeneration in an Intrauterine Hyperglycemic Animal Model.

Okami H, Kawaharada R, Yoshizaki H, Toriumi A, Tsutsumi S, Nakamura A Nutrients. 2023; 15(15).

PMID: 37571372 PMC: 10421171. DOI: 10.3390/nu15153434.

Neuroprotective Effect of 3',4'-Dihydroxyphenylglycol in Type-1-like Diabetic Rats-Influence of the Hydroxytyrosol/3',4'-dihydroxyphenylglycol Ratio.

Rodriguez-Perez M, Perez de Algaba I, Martin-Aurioles E, Arrebola M, Ortega-Hombrados L, Verdugo C Nutrients. 2022; 14(6).

PMID: 35334801 PMC: 8950825. DOI: 10.3390/nu14061146.

Large artery stiffness and brain health: insights from animal models.

Winder N, Reeve E, Walker A Am J Physiol Heart Circ Physiol. 2020; 320(1):H424-H431.

PMID: 33164578 PMC: 7847068. DOI: 10.1152/ajpheart.00696.2020.

Identification of Antiglycative Compounds in Japanese Red Water Pepper (Red Leaf Variant of the Sprout).

Takabe W, Yamaguchi T, Hayashi H, Sugimura N, Yagi M, Yonei Y Molecules. 2018; 23(9).

PMID: 30208642 PMC: 6225476. DOI: 10.3390/molecules23092319.

References

Wendt T, Tanji N, Guo J, Hudson B, Bierhaus A, Ramasamy R . Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy. J Am Soc Nephrol. 2003; 14(5):1383-95. DOI: 10.1097/01.asn.0000065100.17349.ca. View

Wu Y, Shi L, Wu Y, Xu W, Wang L, Ren M . Protective effect of gliclazide on diabetic peripheral neuropathy through Drp-1 mediated-oxidative stress and apoptosis. Neurosci Lett. 2012; 523(1):45-9. DOI: 10.1016/j.neulet.2012.06.038. View

Ramanathan M, Jaiswal A, Bhattacharya S . Differential effects of diazepam on anxiety in streptozotocin induced diabetic and non-diabetic rats. Psychopharmacology (Berl). 1998; 135(4):361-7. DOI: 10.1007/s002130050523. View

Barakat W, Safwet N, El-Maraghy N, Zakaria M . Candesartan and glycyrrhizin ameliorate ischemic brain damage through downregulation of the TLR signaling cascade. Eur J Pharmacol. 2014; 724:43-50. DOI: 10.1016/j.ejphar.2013.12.032. View

Tanji N, Markowitz G, Fu C, Kislinger T, Taguchi A, Pischetsrieder M . Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. J Am Soc Nephrol. 2000; 11(9):1656-1666. DOI: 10.1681/ASN.V1191656. View

Reagan L, Magarinos A, Yee D, Swzeda L, Van Bueren A, McCall A . Oxidative stress and HNE conjugation of GLUT3 are increased in the hippocampus of diabetic rats subjected to stress. Brain Res. 2000; 862(1-2):292-300. DOI: 10.1016/s0006-8993(00)02212-5. View

Beutler E, Duron O, Kelly B . Improved method for the determination of blood glutathione. J Lab Clin Med. 1963; 61:882-8. View

Hartog J, Willemsen S, Van Veldhuisen D, Posma J, van Wijk L, Hummel Y . Effects of alagebrium, an advanced glycation endproduct breaker, on exercise tolerance and cardiac function in patients with chronic heart failure. Eur J Heart Fail. 2011; 13(8):899-908. DOI: 10.1093/eurjhf/hfr067. View

Goh S, Cooper M . Clinical review: The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab. 2008; 93(4):1143-52. DOI: 10.1210/jc.2007-1817. View

10.

Alagiakrishnan K, Sankaralingam S, Ghosh M, Mereu L, Senior P . Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer's disease. Discov Med. 2013; 16(90):277-86. View

11.

Low P, Nickander K . Oxygen free radical effects in sciatic nerve in experimental diabetes. Diabetes. 1991; 40(7):873-7. DOI: 10.2337/diab.40.7.873. View

12.

Wrighten S, Piroli G, Grillo C, Reagan L . A look inside the diabetic brain: Contributors to diabetes-induced brain aging. Biochim Biophys Acta. 2008; 1792(5):444-53. PMC: 3991007. DOI: 10.1016/j.bbadis.2008.10.013. View

13.

Perantie D, Lim A, Wu J, Weaver P, Warren S, Sadler M . Effects of prior hypoglycemia and hyperglycemia on cognition in children with type 1 diabetes mellitus. Pediatr Diabetes. 2008; 9(2):87-95. DOI: 10.1111/j.1399-5448.2007.00274.x. View

14.

Hassan N, El-Bassossy H, Zakaria M . Heme oxygenase-1 induction protects against hypertension associated with diabetes: effect on exaggerated vascular contractility. Naunyn Schmiedebergs Arch Pharmacol. 2012; 386(3):217-26. DOI: 10.1007/s00210-012-0822-3. View

15.

Byun K, Bayarsaikhan E, Kim D, Kim C, Mook-Jung I, Paek S . Induction of neuronal death by microglial AGE-albumin: implications for Alzheimer's disease. PLoS One. 2012; 7(5):e37917. PMC: 3360664. DOI: 10.1371/journal.pone.0037917. View

16.

Wautier M, Chappey O, Corda S, STERN D, Schmidt A, Wautier J . Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab. 2001; 280(5):E685-94. DOI: 10.1152/ajpendo.2001.280.5.E685. View

17.

Yan S, Ramasamy R, Schmidt A . Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging. Biochem Pharmacol. 2010; 79(10):1379-86. PMC: 2854502. DOI: 10.1016/j.bcp.2010.01.013. View

18.

Ghiadoni L, Magagna A, Versari D, Kardasz I, Huang Y, Taddei S . Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension. 2003; 41(6):1281-6. DOI: 10.1161/01.HYP.0000070956.57418.22. View

19.

Vasan S, Foiles P, Founds H . Therapeutic potential of breakers of advanced glycation end product-protein crosslinks. Arch Biochem Biophys. 2003; 419(1):89-96. DOI: 10.1016/j.abb.2003.08.016. View

20.

Yim M, Yim H, Lee C, Kang S, Chock P . Protein glycation: creation of catalytic sites for free radical generation. Ann N Y Acad Sci. 2002; 928:48-53. View